Dr. Rebecca C Dale, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 126 E 2nd St, North Bend, WA 98045 Phone: 425-831-2020 Fax: 425-831-0027 |
News Archive
Springer has entered into a partnership with Universit- degli Studi di Palermo to publish a new English-language book series. The UNIPA Springer Series is a unique cooperation that will showcase research from five core disciplines: medicine, biomedicine and life sciences; engineering and physics; mathematics, statistics and computer sciences; business, economics and law; and human, behavioral and social sciences.
A multinational research group recently published a paper in the journal Lancet Respiratory Medicine which describes the first patient with a severe form of coronavirus disease (COVID-19) that was successfully treated with human recombinant soluble ACE2.
Researchers from the University of Missouri and Imperial College London have found evidence suggesting why vaccines directed against the virus that causes AIDS and many cancers do not work.
CyDex Pharmaceuticals, Inc. today announced a mutual decision with Prism Pharmaceuticals to terminate their existing joint development agreement on novel Captisol-enabled® intravenous formulations of clopidogrel. This provides CyDex with full development and commercialization rights to the product candidate - an injectable formulation of clopidogrel. Clopidogrel is the active ingredient in PLAVIX®, an orally available antiplatelet drug, which currently is marketed by Bristol-Myers Squibb Company and Sanofi-Aventis, Inc.
› Verified 3 days ago